Navigation Links
Mystery unfolds about the Ginkgo biloba extract!

Georgetown University Medical Centre scientists have unravelled mystery surrounding the leaf extract of Ginkgo biloba tree in reducing aggressive cancer in // animals.

Anticancer Research journal (Jan-Feb) features the study. The investigators reported that treating mice with this extract before and after implanting human breast or brain (glioma) tumours decreased expression of a cell receptor associated with invasive cancer.

An 80 percent decreased incidence was observed as long as the extract was used, compared to untreated mice, and also reduced the size of the brain tumours, but temporarily, and to a lesser extent.

Ginkgo biloba extract is a popular supplement that comes from the leaves of the Gingko tree, which is indigenous to Japan, Korea and China but can be found all over the world.

In the words of senior author, Vassilios Papadopoulos, DPharm, PhD, Director, Biomedical Graduate Research Organization and Associate Vice President of Georgetown University Medical Centre, "It is very encouraging that Ginkgo biloba appeared to reduce the aggressiveness of these cancers, because it suggests that the leaves could be useful in some early stage diseases to prevent them from becoming invasive, or spreading. But I must stress that this is a study in mice, and so we cannot say what anticancer effects, if any, Gingko biloba might offer humans. In fact, we have found that most life forms, including plants, insects, and animals, have receptors like these that help regulate growth. Accelerated growth requires production of new cell membranes, and one of the main components of membranes is cholesterol."

The researchers also knew that steroids help regulate brain function, and they found over-expression of PBR is also associated with a variety of neurological disorders.

On stressing the need for this new study he said that one aim of this new study, then, was to find whether other cancer cell lines also over- express PBR. The other part of the research was to see if Ginkgo biloba would show any anticancer effects on these cancer cell lines, and concluded that the extract did nothing to cancers that were not invasive, but significantly slowed the growth of aggressive cancer cells.

The next step of Papadopoulos is to examine the notion that a cancer diagnosis might increase production of stress steroids such as corticosteroids through PBR over-expression, and it is this stress that, in effect, pushes a tumour to become invasive. He says, “Ginkgo biloba could possibly reduce this stress by tamping down PBR."


'"/>




Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Understanding The Mystery Behind Sleepless Nights
3. Mystery of nacrolepsy uncovered
4. Cholesterol Mystery Solved By Nobel Laureates
5. A Step Towards Unraveling The Schizophrenia And Depression Mystery
6. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
7. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
8. Mystery behind Brain activity during recalling events disentangled
9. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
10. Mystery Of The Placebo Effect, Yet To Be Solved
11. Dry Earwax Mystery Solved: Ear Wax Gene Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: